Vitrolife
A global provider of medical devices and genetic testing services for IVF clinics to improve outcomes.
VITR | ST
Overview
Corporate Details
- ISIN(s):
- SE0011205202 (+1 more)
- LEI:
- 5493001WDZMONMSPPR49
- Country:
- Sweden
- Address:
- Box 9080, 400 92 Göteborg
- Website:
- https://www.vitrolife.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Vitrolife is a global provider of medical devices and genetic testing services for the reproductive health market. With over 30 years of experience in assisted reproduction, the company develops and supplies products and services to IVF clinics worldwide. Its offerings are designed to improve treatment outcomes by supporting every stage of the IVF journey. Key products include pioneering time-lapse technology, such as the EmbryoScope+ system, which utilizes AI for enhanced embryo evaluation and selection. Vitrolife also provides comprehensive customer support and education through its Vitrolife Academy, offering workshops and clinical guidance. The company emphasizes stringent quality control as a core aspect of its operations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-07-17 08:00 |
Interim Report
|
Swedish | 2.1 MB | ||
| 2025-07-17 08:00 |
Interim Report
|
English | 2.9 MB | ||
| 2025-04-30 09:09 |
Post-Annual General Meeting Information
Kommuniké från årsstämma i Vitrolife AB (publ)
|
Swedish | 136.9 KB | ||
| 2025-04-30 09:09 |
Post-Annual General Meeting Information
Report from Annual General Meeting of Vitrolife AB (publ)
|
English | 137.2 KB | ||
| 2025-04-29 16:56 |
Post-Annual General Meeting Information
Kommuniké från årsstämma i Vitrolife AB (publ)
|
Swedish | 156.5 KB | ||
| 2025-04-29 16:56 |
Post-Annual General Meeting Information
Report from Annual General Meeting of Vitrolife AB (publ)
|
English | 160.1 KB | ||
| 2025-04-24 08:00 |
Interim Report
|
Swedish | 2.1 MB | ||
| 2025-04-24 08:00 |
Quarterly Report
|
English | 2.2 MB | ||
| 2025-03-25 18:30 |
Pre-Annual General Meeting Information
Notice to attend the Annual General Meeting of Vitrolife AB (publ)
|
English | 386.7 KB | ||
| 2025-03-25 18:30 |
Pre-Annual General Meeting Information
Kallelse till årsstämma i Vitrolife AB (publ)
|
Swedish | 328.4 KB | ||
| 2025-02-21 13:00 |
Board/Management Information
Vitrolife Group utser Ermanno Sironi till Chief Operating Officer
|
Swedish | 132.2 KB | ||
| 2025-02-21 13:00 |
Board/Management Information
The Vitrolife Group appoints Ermanno Sironi as Chief Operating Officer
|
English | 131.8 KB | ||
| 2025-01-30 08:01 |
Annual Report
|
Swedish | 3.0 MB | ||
| 2025-01-30 08:01 |
Annual Report
|
English | 3.0 MB | ||
| 2024-10-24 08:01 |
Quarterly Report
|
Swedish | 3.0 MB |
Automate Your Workflow. Get a real-time feed of all Vitrolife filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Vitrolife via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-04-26 | Patrik Tolf | Other | Buy | 2,500 | 535,045.25 SEK |
| 2023-02-02 | Ricardo Capella | Other | Buy | 3,000 | 739,200.00 SEK |
| 2022-10-31 | Patrik Tolf | Other | Buy | 3,000 | 537,000.00 SEK |
| 2022-09-28 | Ricardo Capella | Other | Buy | 3,000 | 484,800.00 SEK |
| 2021-09-06 | Mikael Engblom | Other | Sell | 700 | 359,100.00 SEK |
| 2021-09-06 | Mikael Engblom | Other | Sell | 538 | 274,380.00 SEK |
| 2021-09-06 | Mikael Engblom | Other | Sell | 500 | 257,500.00 SEK |
| 2021-09-06 | Mikael Engblom | Other | Sell | 500 | 256,000.00 SEK |
| 2021-09-06 | Mikael Engblom | Other | Sell | 490 | 249,410.00 SEK |
| 2021-09-06 | Mikael Engblom | Other | Sell | 482 | 245,820.00 SEK |
/other/Spermosens_AB_publ-logo.jpg){kind=logo}
